NO955126L - Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav - Google Patents

Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav

Info

Publication number
NO955126L
NO955126L NO955126A NO955126A NO955126L NO 955126 L NO955126 L NO 955126L NO 955126 A NO955126 A NO 955126A NO 955126 A NO955126 A NO 955126A NO 955126 L NO955126 L NO 955126L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
therapeutic uses
low polyamine
food
polyamine food
Prior art date
Application number
NO955126A
Other languages
English (en)
Other versions
NO955126D0 (no
Inventor
Jacques-Philippe Moulinoux
Veronique Quemener
Original Assignee
Univ Rennes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9307586A external-priority patent/FR2706254B1/fr
Application filed by Univ Rennes filed Critical Univ Rennes
Publication of NO955126D0 publication Critical patent/NO955126D0/no
Publication of NO955126L publication Critical patent/NO955126L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

En spiselig blanding bestående av en næringsblanding med et polyamininnhold på mindre enn 1600 pikomol/g. Blandingen kan brukes som et middel mot kreft, som et smertestillende middel, som et stimuleringsmiddel for immunsystemet, da spesi- elt for å stimulere NK-celleaktivitet og den endogene inter- leukin-2-produksjonen, samt som et middel for å undertrykke appetitten.
NO955126A 1993-06-17 1995-12-15 Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav NO955126L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9307586A FR2706254B1 (fr) 1993-06-17 1993-06-17 Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines.
FR9314761A FR2706255B1 (fr) 1993-06-17 1993-12-03 Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques.
PCT/FR1994/000736 WO1995000041A1 (fr) 1993-06-17 1994-06-17 Composition a usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications therapeutiques

Publications (2)

Publication Number Publication Date
NO955126D0 NO955126D0 (no) 1995-12-15
NO955126L true NO955126L (no) 1996-02-15

Family

ID=26230425

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955126A NO955126L (no) 1993-06-17 1995-12-15 Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav

Country Status (8)

Country Link
EP (1) EP0703731B1 (no)
AT (1) ATE164731T1 (no)
AU (1) AU7076994A (no)
CA (1) CA2165481A1 (no)
DE (1) DE69409518D1 (no)
FR (1) FR2706255B1 (no)
NO (1) NO955126L (no)
WO (1) WO1995000041A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE422359T1 (de) 1997-04-15 2009-02-15 Csir Verbindungen und pharmazeutische zusammensetzungen mit appetitunterdrückender aktivität
GB2396815B (en) 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
FR2858231B1 (fr) * 2003-07-31 2006-02-10 Univ Rennes Utilisation nouvelle d'une composition alimentaire a usage humain pauvre en polyamines pour la realisation d'un aliment therapeutique
FR2886154B1 (fr) * 2005-05-27 2010-03-26 Cothera Composition pour retarder le developpement de la maladie d'alzheimer
FR2896127B1 (fr) * 2006-01-17 2008-04-11 Univ Rennes I Etablissement Pu Utilisation nouvelle d'une composition alimentaire a usage humain ou veterinaire pauvre en polyamines pour la realisation d'un aliment therapeutique
HRP20140887T1 (hr) 2009-05-14 2014-11-21 Arizona Board Of Regents On Behalf Of University Of Arizona Dijagnoza karcinoma i lijeäśenje, koje se temelji na odc1 genotipu
FR2946534B1 (fr) * 2009-06-12 2011-10-14 Univ Rennes Utilisation d'alkylglycerols pour la preparation de medicaments.
EP2568978B1 (en) * 2010-05-14 2019-04-24 Arizona Board of Regents on Behalf of University of Arizona Cancer prevention and treatment based on dietary polyamine content
FR2967868B1 (fr) * 2010-11-30 2012-11-09 Univ Dauvergne Clermont I Utilisation d'une composition alimentaire dans le traitement et/ou la prevention des douleurs neuropathiques induites par un agent anticancereux
FR2979241B1 (fr) * 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
FR2980709B1 (fr) 2011-09-29 2013-10-25 Nutrialys Medical Nutrition Sa Compositions contenant de la spermine et compositions pharmaceutiques les contenant
FR2985427B1 (fr) * 2012-01-10 2016-07-15 Nutrialys Medical Nutrition Sa Compositions contenant de l'agmatine et leurs utilisations dans la preparation de medicaments ou de substances nutraceutiques
PT2912193T (pt) 2012-10-29 2018-11-29 Arizona Board Of Regents On Behalf Of Univ Of Arizona Marcadores preditivos para terapêuticas de cancro de inibidor de poliamina
JP2017519770A (ja) 2014-06-18 2017-07-20 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ Ｏｄｃ１遺伝子型に基づく癌腫の診断および処置
WO2016130918A1 (en) 2015-02-12 2016-08-18 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for treating neuroblastoma
CA3003149C (en) 2015-10-30 2023-10-31 Cancer Prevention Pharmaceuticals, Inc. Eflornithine and sulindac, fixed dose combination formulation
WO2020236562A1 (en) 2019-05-17 2020-11-26 Cancer Prevention Pharmaceuticals, Inc. Methods for treating familial adenomatous polyposis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112123A (en) * 1976-07-21 1978-09-05 Beatrice Foods Co. Nutritionally balanced single food composition and method of production
US4201788A (en) * 1976-10-20 1980-05-06 University Patents, Inc. Process for alleviating proliferative skin diseases
US4207315A (en) * 1976-10-20 1980-06-10 University Patents, Inc. Process for treating proliferative skin diseases using certain diamino compounds
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤
NZ212053A (en) * 1984-05-17 1988-02-29 Merrell Dow Pharma Polyamine containing pharmaceutical compositions for treating neoplasms
US4859452A (en) * 1986-01-17 1989-08-22 Board Of Regents, The University Of Texas System Methods for the reduction of difluoromethylornithine associated toxicity
JPS62263127A (ja) * 1986-05-06 1987-11-16 メレルダウフア−マス−テイカルズ　インコ−ポレ−テツド 自己由来のｌａｋ細胞、インタ−ロイキン−２、及びオルニチンデカルボキシラ−ゼ阻害剤による腫瘍の処置

Also Published As

Publication number Publication date
CA2165481A1 (en) 1995-01-05
FR2706255A1 (fr) 1994-12-23
NO955126D0 (no) 1995-12-15
AU7076994A (en) 1995-01-17
WO1995000041A1 (fr) 1995-01-05
ATE164731T1 (de) 1998-04-15
EP0703731B1 (fr) 1998-04-08
EP0703731A1 (fr) 1996-04-03
FR2706255B1 (fr) 1995-10-27
DE69409518D1 (de) 1998-05-14

Similar Documents

Publication Publication Date Title
NO955126D0 (no) Mat-og/eller farmasöytisk blanding med lavt polyamininnhold og terapeutiske anvendelser derav
GR3035627T3 (en) A mammalian cytokine, il-11.
AU590618B2 (en) Stable formulation of biologically active proteins for parenteral injection
RU96108586A (ru) Способ приготовления премикса
PL338219A1 (en) Therapeutic and dietary compositions containing necessary unsaturated fatty acids and biologically active disulphides
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
EG18379A (en) Novel pharmacological compounds
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
ATE66370T1 (de) Pharmazeutisches praeparat zur verzoegerten freigabe von ibuprofen.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
ZA895840B (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
EP0813409A4 (en) TREATMENT OF DISEASES CAUSED BY THE CYTOKIN GROWTH FACTOR
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
FI864164A7 (fi) Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä.
HU9303230D0 (en) Use of lanoline derivatives for promotion of transdermal resorption of drugs and other biological substances
NO933323L (no) Nærings- og medikamentblandinger på basis av kitosan for administrering til drövtyggere
AU5505990A (en) Polysaccharide mixture with immune stimulating and antiproliferating effect, method of production and medicines containing the substances
Misago et al. Enhancing effects of IL-2 on M-CSF production by human peripheral blood monocytes
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
GR3015373T3 (en) 2-Halogen-substituted N-indolyl sulfonic-acid amides, process for their preparation and their pharmaceutical use.
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ES2051788T3 (es) Un producto farmaceutico.
KR920700683A (ko) t-PA의 가용화